News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|September 1, 2016

Value-Based Decisions in Diabetes: Evaluating Safety, Efficacy, and Costs of Therapeutic Alternatives

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

CMS. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute

ByGiuliana Grossi

September 9th 2026

Yet Khor, MD, PhD | Image credit: Monash University

Significant Emphysema Linked to Worse ILD Outcomes: Yet Khor, MD, PhD

BySabrina McCrear,Yet Khor, MD, PhD

September 9th 2026

Doctor holding animated liver | Image Credit: Aliaksandr Marko - stock.adobe.com

MASH Comorbidities May Drive Worse Transplant Outcomes

ByBrooke McCormick

September 9th 2026

Lungs | Image credit: Ahmad - AdobeStock

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

ByLaura Joszt, MA

September 8th 2026

FDA approval. | Image credit: @Сергей Шиманович-stock.adobe.com.jpeg

FDA Approves First Disease-Modifying Treatment for AxD

BySabrina McCrear

September 8th 2026

Trending on AJMC

The True Cost of Running a Community CAR T-Cell Program

Bringing CAR T-Cell Therapy Into Community Cancer Centers

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute

Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI